Clinical Trial Update: Vivacit-E Post-market Follow-up Study [NA]

View source ↗

Summary

This document reports that the Vivacit-E post-market follow-up study is currently active but not recruiting, evaluating osteoarthritis, avascular necrosis of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Developmental Dysplasia of the Hip
• Osteoarthritis
• Post-traumatic Arthritis

Drugs mentioned

• Vivacit-E

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Avascular Necrosis of Bone of Hip | NA | Status: ACTIVE_NOT_RECRUITING